Previous studies have shown that BBR decreased the phosphorylation of PI3K/AKT, ERK, and GSK3β in B16F10 melanoma cells and inhibited the activation of EGFR in these tumors [32, 33]. This evidence concerns the gene EGFR and melanoma.